175 related articles for article (PubMed ID: 37833937)
1. Expression of Cytoskeletal Proteins (GFAP, Vimentin), Proapoptotic Protein (Caspase-3) and Protective Protein (S100) in the Epileptic Focus in Adults and Children with Drug-Resistant Temporal Lobe Epilepsy Associated with Focal Cortical Dysplasia.
Sitovskaya D; Zabrodskaya Y; Parshakov P; Sokolova T; Kudlay D; Starshinova A; Samochernykh K
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833937
[TBL] [Abstract][Full Text] [Related]
2. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
Mao C; Jin L; Dou W; Lu Q; Zhou L; Ren H; Zhao Y; Feng F; Guo Y; Gao J
Epilepsy Res; 2019 Nov; 157():106189. PubMed ID: 31472401
[TBL] [Abstract][Full Text] [Related]
3. Temporal lobe epilepsy and focal cortical dysplasia in children: A tip to find the abnormality.
Bartolini L; Whitehead MT; Ho CY; Sepeta LN; Oluigbo CO; Havens K; Freilich ER; Schreiber JM; Gaillard WD
Epilepsia; 2017 Jan; 58(1):113-122. PubMed ID: 27864929
[TBL] [Abstract][Full Text] [Related]
4. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
[TBL] [Abstract][Full Text] [Related]
5. Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.
Dührsen L; Sauvigny T; House PM; Stodieck S; Holst B; Matschke J; Schön G; Westphal M; Martens T
J Neurosurg; 2018 Jun; 128(6):1668-1673. PubMed ID: 28753112
[TBL] [Abstract][Full Text] [Related]
6. Calcium-binding proteins in focal cortical dysplasia.
Kuchukhidze G; Wieselthaler-Hölzl A; Drexel M; Unterberger I; Luef G; Ortler M; Becker AJ; Trinka E; Sperk G
Epilepsia; 2015 Aug; 56(8):1207-16. PubMed ID: 26081613
[TBL] [Abstract][Full Text] [Related]
7. [Structural heterogeneity of epileptic foci in local drug-resistant epilepsy].
Sitovskaya DA; Zabrodskaya YM; Sokolova TV; Kuralbaev AK; Nezdorovina VG; Dobrogorskaya LN
Arkh Patol; 2020; 82(6):5-15. PubMed ID: 33274620
[TBL] [Abstract][Full Text] [Related]
8. The specific DNA methylation landscape in focal cortical dysplasia ILAE type 3D.
Wang DD; Katoch M; Jabari S; Blumcke I; Blumenthal DB; Lu DH; Coras R; Wang YJ; Shi J; Zhou WJ; Kobow K; Piao YS
Acta Neuropathol Commun; 2023 Aug; 11(1):129. PubMed ID: 37559109
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of 92 patients with temporal lobe focal cortical dysplasia identified by pathological examination.
Wu J; Li W; Chen Y; Kang L; Zhao W
J Clin Neurosci; 2014 Dec; 21(12):2170-4. PubMed ID: 25065846
[TBL] [Abstract][Full Text] [Related]
10. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
[TBL] [Abstract][Full Text] [Related]
11. Increased subcortical oligodendroglia-like cells in pharmacoresistant focal epilepsy in children correlate with extensive epileptogenic zones.
Sakuma S; Halliday WC; Nomura R; Baba S; Sato Y; Okanari K; Nakajima M; Widjaja E; Boelman C; Ochi A; Snead OC; Rutka JT; Drake J; Miller S; Otsubo H
Epilepsia; 2016 Dec; 57(12):2031-2038. PubMed ID: 27859041
[TBL] [Abstract][Full Text] [Related]
12. Transcription of intermediate filament genes is enhanced in focal cortical dysplasia.
Taylor JP; Sater R; French J; Baltuch G; Crino PB
Acta Neuropathol; 2001 Aug; 102(2):141-8. PubMed ID: 11563628
[TBL] [Abstract][Full Text] [Related]
13. Dual/double pathology in neurocysticercosis causing drug resistant epilepsy - Chance association or causal?
Mhatre R; Poyuran R; Arimappamagan A; Sinha S; Kulanthaivelu K; Kenchaiah R; Ajay A; Chowdary RM; Saini J; Bharath RD; Zanzmera P; Seetharam R; Sadashiva N; Jamuna R; Satishchandra P; Malla BR; Sk S; Anita M
Epilepsy Res; 2020 Dec; 168():106472. PubMed ID: 33137632
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy.
Griffin WS; Yeralan O; Sheng JG; Boop FA; Mrak RE; Rovnaghi CR; Burnett BA; Feoktistova A; Van Eldik LJ
J Neurochem; 1995 Jul; 65(1):228-33. PubMed ID: 7790864
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome characteristics in mesial temporal lobe epilepsy with and without associated cortical dysplasia.
Schmeiser B; Hammen T; Steinhoff BJ; Zentner J; Schulze-Bonhage A
Epilepsy Res; 2016 Oct; 126():147-56. PubMed ID: 27500381
[TBL] [Abstract][Full Text] [Related]
16. Cortical expression of IL1-β, Bcl-2, Caspase-3 and 9, SEMA-3a, NT-3 and P-glycoprotein as biological markers of intrinsic severity in drug-resistant temporal lobe epilepsy.
Vega-García A; Orozco-Suárez S; Villa A; Rocha L; Feria-Romero I; Alonso Vanegas MA; Guevara-Guzmán R
Brain Res; 2021 May; 1758():147303. PubMed ID: 33516813
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of postoperative seizure outcomes in older patients with temporal lobe epilepsy.
He X; Zhou J; Guan Y; Zhai F; Li T; Luan G
Neurosurg Focus; 2020 Apr; 48(4):E7. PubMed ID: 32234988
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
[TBL] [Abstract][Full Text] [Related]
20. Corpora amylacea in the neocortex in patients with temporal lobe epilepsy and focal cortical dysplasia.
Estupiñán-Díaz BO; Morales-Chacón LM; García-Maeso I; Lorigados-Pedre L; Báez-Martín M; García-Navarro ME; Trápaga-Quincoses O; Quintanal-Cordero N; Prince-López J; Bender-del Busto JE;
Neurologia; 2015 Mar; 30(2):90-6. PubMed ID: 25440067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
